Oleg Akilov, MD, PhD
SESSIONS
U021 Immunomodulatory Therapies and Cutaneous Lymphoma: Associations, Risks, and Clinical Implications
Mar 27, 2026
•
3:30 PM - 4:30 PM
•
Mile High 3A
DISCLOSURES
Actelion – Investigator(Grants/Research Funding); Adaptive Biotechnologies Corp – Investigator(Grants/Research Funding); Helsinn Healthcare – Advisory Board(Honoraria); Kyowa Hakko Kirin Pharma, Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding), Speaker(Honoraria); Mallinckrodt Pharmaceuticals – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); SkinJect Inc. – Consultant (1099 relationship)(Fees); Therakos, Inc. – Speaker(Honoraria); Trillium Therapeutics, Inc – Investigator(Grants/Research Funding);